Exogenous overexpression of MYCN in NB cell lines can cause metabolic reprogramming of NB cells and sensitivity to the glycolysis inhibitor 2-deoxyglucose (Tjaden et al., 2020). The gene discussed is MYCN; the disease is neuroblastoma.